Filamentous influenza A virus infection predisposes mice to fatal septicemia following superinfection with Streptococcus pneumoniae serotype 3

Infection and Immunity

Volumn 75, Issue 6, 2007, Pages 3102-3111

  Speshock, Janice L ^a   Doyon Reale, Nicole ^a   Rabah, R ^b   Neely, Melody N ^a   Roberts, Paul C ^a,c  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

^c CENTER FOR MOLECULAR MEDICINE AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL SUPERINFECTION; BRAIN; CONTROLLED STUDY; CYTOKINE PRODUCTION; FATALITY; FEMALE; INFLAMMATORY INFILTRATE; INFLUENZA; INFLUENZA VIRUS A; LUNG; LUNG LAVAGE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; SEPTICEMIA; SEROTYPE; SPLEEN; STREPTOCOCCUS INFECTION; TISSUE DISTRIBUTION;

ANIMALS; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS; PNEUMOCOCCAL INFECTIONS; SEPSIS; STREPTOCOCCUS PNEUMONIAE; SUPERINFECTION;

EID: 34249909209     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.01943-06     Document Type: Article

References (38)

1. Abramson, J. S., and E. L. Mills. 1988. Depression of neutrophil function induced by viruses and its role in secondary microbial infections. Rev. Infect. Dis. 10:326-341.
2. Abramson, J. S., J. C. Lewis, D. S. Lyles, K. A. Heller, E. L. Mills, and D. A. Bass. 1982. Inhibition of neutrophil lysosome-phagosome fusion associated with influenza infection in vitro: role in depressed bactericidal activity. J. Clin. Investig. 69:1393-1397.
3. Ada, G. L., and B. T. Perry. 1958. Properties of the nucleic acid of the Ryan strain of filamentous influenza virus. J. Gen. Microbiol. 19:40-54.
4. Ada, G. L., B. T. Perry, and A. Abbot. 1958. Biological and physical properties of the Ryan strain of filamentous influenza virus. J. Gen. Microbiol. 19:23-39.
5. Azoulay, E., H. Attalah, K. Yang, S. Herigault, H. Jouault, C. Brun-Buisson, L. Brochard, A. Harf, B. Schlemmer, and C. Delclaux. 2003. Exacerbation with granulocyte colony-stimulating factor of prior acute lung injury during neutropenia recovery in rats. Crit. Care Med. 31:157-165.
6. Briles, D. E., R. C. Tart, E. Swiatlo, J. P. Dillard, P. Smith, K. A. Benton, B. A. Ralph, A. Brooks-Walter, M. J. Crain, S. K. Hollingshead, and L. S. McDaniel. 1998. Pneumococcal diversity: consideration for new vaccine strategies with emphasis on pneumococcal surface protein A (PspA). Clin. Microbiol. Rev. 11:645-657.
7. Carollo, M., C. M. Hogaboam, S. L. Kunkel, S. Delaney, M. I. Christie, and M. Peretti. 2001. Analysis of the temporal expression of chemokines and chemokine receptors during experimental granulomatous inflammation: role and expression of MIP-1α and MCP-1. Br. J. Pharmacol. 134:1166-1179.
8. Choppin, P. W., J. S. Murphy, and I. Tamm. 1960. Studies of two kinds of virus particles which comprise influenza A virus strains. J. Exp. Med. 112:945-952.
9. Colamussi, M. L., M. R. White, E. Crouch, and K. L. Hartshorn. 1999. Influenza A virus accelerates neutrophil apoptosis and markedly potentiates apoptotic effects of bacteria. Blood 93:2395-2403.
10. Dale, D. C., M. A. Bonilla, M. W. Davis, A. M. Nakanishi, W. P. Hammond, J. Kurtzberg, W. Wang, A. Jakubowski, E. Winton, P. Lalezari, et al. 1993. A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood 81:2496-2502.
11. Davison, V. E., and B. A. Sanford. 1981. Adherence of Staphylococcus aureus to influenza A virus-infected Madin-Darby canine kidney cell cultures. Infect. Immun. 32:118-126.
12. Davison, V. E., and B. A. Sanford. 1982. Factors influencing adherence of Staphylococcus aureus to influenza A virus-infected cell cultures. Infect. Immun. 37:946-955.
13. Diab, A., H. Abdalla, H. L. Li, F. D. Shi, J. Zhu, B. Hojberg, L. Lindquist, B. Wretlind, M. Bakhiet, and H. Link. 1999. Neutralization of macrophage inflammatory protein 2 (MIP-2) and MIP-1α attenuates neutrophil recruitment in the central nervous system during experimental bacterial meningitis. Infect. Immun. 67:2590-2601.
14. Ellis, T. N., and B. L. Beaman. 2004. Interferon-γ activation of polymorphonuclear neutrophil function. Immunology 112:2-12.
15. Heil, G., D. Hoelzer, M. A. Sanz, K. Lechner, J. A. Liu Yin, G. Papa, L. Noens, J. Szer, A. Ganser, C. O'Brien, J. Matcham, and A. Barge. 1997. A randomized, double-blind placebo-controlled, phase III study of filgrastim in remission induction and consolidation therapy for adults with de novo acute myeloid leukemia. Blood 90:4710-4718.
16. Hitt, E. 2004. S. pneumoniae serotype 3 not covered by 7-valent vaccine. Medscape Med. News 2004:470964.
17. Jones, W. T., and J. H. Menna. 1982. Influenza type A virus-mediated adherence of type 1a group B Streptococci to mouse tracheal tissue in vivo. Infect. Immun. 38:791-794.
18. Kinoshita, M., H. Mochizuki, and S. Ono. 1999. Pulmonary neutrophil accumulation following human endotoxemia. Chest 116:1709-1715.
19. Kleinerman, E. S., C. A. Daniels, R. P. Polisson, and R. Synderman. 1976. Effect of virus infection of the inflammatory response: depression of macrophage accumulation in influenza-infected mice. Am. J. Pathol. 85:373-382.
20. LeVine, A. M., V. Koeningsknecht, and J. M. Stark. 2001. Decreased pulmonary clearance of S. pnuemoniae following influenza A infection in mice. J. Virol. Methods 94:173-186.
21. -ΔΔCT method. Methods 25:402-408.
22. Lomas-Neira, J. L., C.-S. Chung, D. E. Wesche, M. Perl, and A. Ayala. 2005. In vivo gene silencing (with siRNA) of pulmonary expression of MIP-2 versus KC results in divergent effects on hemorrhage-induced, neutrophil-mediated septic acute lung injury. J. Leukoc. Biol. 77:846-853.
23. McCullers, J. A. 2006. Insights into the interaction between influenza virus and pneumococcus. Clin. Microbiol. Rev. 19:571-582.
24. McCullers, J. A., and J. E. Rehg. 2002. Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor. J. Infect. Dis. 186:341-350.
25. McCullers, J. A., and K. C. Bartmess. 2003. Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae. J. Infect. Dis. 187:1000-1009.
26. Niekerson, C. L., and G. J. Jakab. 1990. Pulmonary antibacterial defenses during mild and severe influenza virus infection. Infect. Immun. 58:2809-2814.
27. Okamoto, S., S. Kawabata, I. Nakagawa, Y. Okuno, T. Goto, K. Sano, and S. Hamada. 2003. Influenza A virus-infected hosts boost an invasive type of Streptococcus pyogenes infection in mice. J. Virol. 77:4104-4112.
28. Otto, V. I., U. E. Heinzel-Pleines, S. M. Gloor, O. Trenti, T. Kossmann, and M. C. Morganti-Kossmann. 2000. sICAN-1 and TNF-alpha induce MIP-2 with distinct kinetics in astrocytes and brain microvascular endothelial cells. J. Neurosci. Res. 60:733-742.
29. Overbergh, L., A. Giuletti, D. Valckx, R. Decallonne, R. Bouillon, and C. Mathieu. 2003. The use of real-time reverse transcriptase PCR for the quantification of cytokine gene expression. J. Biomol. Tech. 14:33-43.
30. Peltola, V. T., K. G. Murti, and J. A. McCullers. 2005. Influenza virus neuraminidase contributes to secondary bacterial pneumonia. J. Infect. Dis. 192:249-257.
31. Plotkowski, M.-C. 1986. Adherence of type I Streptococcus pneumoniae to tracheal epithelium of mice infected with influenza A/PR8 virus. Am. Rev. Respir. Dis. 134:1040-1044.
32. Reed, L. J., and H. Muench. 1938. A simple method of estimating fifty percent end points. Am. J. Hyg. 27:493-497.
33. Roberts, P. C., R. A. Lamb, and R. W. Compans. 1998. The M1 and M2 proteins of influenza A virus are important determinants in filamentous particle formation. Virology 240:127-137.
34. Stevens, K. M. 1976. Cardiac stroke volume as a determinant of influenzal fatality. Med. Intell. 295:1363-1366.
35. van der Sluijs, K., L. J. van Elden, M. Nijhuis, R. Schuurman, J. M. Pater, S. Florquin, M. Goldman, H. M. Jansen, R. Lutter, and T. van der Poll. 2004. IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection. J. Immunol. 172:7603-7609.
36. Watt, J. P., K. L. O'Brien, S. Katz, M. A. Bronsdon, J. Elliott, J. Dallas, M. J. Perilla, R. Reid, L. Murrow, R. Facklam, M. Santosham, and C. G. Whitney. 2004. Nasopharyngeal versus oropharyngeal sampling for detection of pneumococcal carriage in adults. J. Clin. Microbiol. 42:4974-4976.
37. Wiedermann, F. J. 2005. Acute lung injury during G-CSF-induced neutropenia recovery: effect of G-CSF on pro- and anti-inflammatory cytokines. Bone Marrow Transpl. 36:731.
38. Wu, H.-Y., A. Virolainen, B. Mathews, J. King, M. W. Russell, and D. E. Briles. 1997. Establishment of a Streptococcus pneumoniae nasopharyngeal colonization model in adult mice. Microb. Pathog. 23:127-137.